One of the emodin derivatives, 10-(4-acetamidobenzylidene)-9-anthrone, was found to be more potent than emodin in suppressing the tyrosine phosphorylation of p185neu and inhibiting the proliferation and transformation of HER-2/neu-overexpressing human breast cancer cells. The gene discussed is ERBB2; the disease is breast cancer.